IKT
Inhibikase·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
IKT Profile
Inhibikase Therapeutics, Inc.
A clinical stage pharmaceutical company that develops therapeutics for Parkinson’s Disease and related brain disorders
Biological Technology
06/03/2010
12/23/2020
NASDAQ Stock Exchange
15
12-31
Common stock
1000 N. West Street, Suite 1200, Wilmington, DE 19801
--
Inhibikase Therapeutics, Inc., was incorporated as a Delaware corporation on June 3, 2010. The company is a clinical-stage pharmaceutical company developing therapies for Parkinson's disease or PD and related diseases that occur inside and outside the brain.
